Auflistung Universitätsbibliographie nach Autor "Gallwitz, Baptist"

Anzeige der Dokumente 1-20 von 72

Nächste Seite >>

2-year efficacy and safety of linagliptin compared with glimepiride in patients with type 2 diabetes inadequately controlled on metformin: a randomised, double-blind, non-inferiority trial

Gallwitz, Baptist; Rosenstock, Julio; Rauch, Thomas; Bhattacharya, Sudipta; Patel, Sanjay; von Eynatten, Maximilian; Dugi, Klaus A.; Woerle, Hans-Juergen (2012)
A Decision Support Tool for Appropriate Glucose-Lowering Therapy in Patients with Type 2 Diabetes

Javier Ampudia-Blasco, F.; Benhamou, Pierre Yves; Charpentier, Guillaume; Consoli, Agostino; Diamant, Michaela; Gallwitz, Baptist; Khunti, Kamlesh; Mathieu, Chantal; Ridderstrale, Martin; Seufert, Jochen; Tack, Cees; Vilsboll, Tina; Tra-Mi Phan; Stoevelaar, Herman (2015)
A safety evaluation of empagliflozin plus linagliptin for treating type 2 diabetes

Gallwitz, Baptist (2017)
Ambulante Diabetesversorgung in Deutschland – Ergebnisse einer Strukturerhebung in diabetologischen Praxen und Einrichtungen

Reichert, Dorothea; Scheper, Nikolaus; Mueller-Wieland, Dirk; Haeckl, Dennis; Bayer, Andreas; Horst, Michael; Gallwitz, Baptist (2018)
Behandlung des Diabetes mellitus Typ 2

Matthaei, S.; Bierwirth, R.; Fritsche, A.; Gallwitz, B.; Haering, H. -U.; Joost, H. -G.; Kellerer, M.; Kloos, C.; Kunt, T.; Nauck, M.; Schernthaner, G.; Siegel, E.; Thienel, F. (2012)
C-11-methionine PET/CT after inconclusive Tc-99m-MIBI-SPECT/CT for localisation of parathyroid adenomas in primary hyperparathyroidism

Braeuning, U.; Pfannenberg, C.; Gallwitz, B.; Teichmann, R.; Mueller, M.; Dittmann, H.; Reimold, M.; Bares, R. (2015)
Clinical Perspectives on the Use of Subcutaneous and Oral Formulations of Semaglutide

Gallwitz, Baptist; Giorgino, Francesco (2021)
Clinical perspectives on the use of the GIP/GLP-1 receptor agonist tirzepatide for the treatment of type-2 diabetes and obesity

Gallwitz, Baptist (2022)
Clinical Use of DPP-4 Inhibitors

Gallwitz, Baptist (2019)
Contribution of insulin deficiency and insulin resistance to the development of type 2 diabetes: nature of early stage diabetes

Gallwitz, Baptist; Kazda, Christof; Kraus, Petra; Nicolay, Claudia; Schernthaner, Guntram (2013)
Diabetes mellitus an der Schnittstelle von Pädiatrie und Erwachsenenmedizin

Gallwitz, B.; Neu, A. (2018)
Diabetestherapie bei herzkranken Patienten : Orale Antidiabetika und Glucagon-like Peptide 1 (GLP-1)-Rezeptoragonisten

Gallwitz, Baptist (2023)
Dissociation of GLP-1 and insulin association with food processing in the brain: GLP-1 sensitivity despite insulin resistance in obese humans

Heni, Martin; Kullmann, Stephanie; Gallwitz, Baptist; Haering, Hans-Ulrich; Preissl, Hubert; Fritsche, Andreas (2015)
DPP4 gene variation affects GLP-1 secretion, insulin secretion, and glucose tolerance in humans with high body adiposity

Boehm, Anja; Wagner, Robert; Machicao, Fausto; Holst, Jens Juul; Gallwitz, Baptist; Stefan, Norbert; Fritsche, Andreas; Haering, Hans-Ulrich; Staiger, Harald (2017)
Effect of once-weekly dulaglutide on glycated haemoglobin (HbA1c) and fasting blood glucose in patient subpopulations by gender, duration of diabetes and baseline HbA1c

Gallwitz, Baptist; Dagogo-Jack, Samuel; Thieu, Vivian; Garcia-Perez, Luis-Emilio; Pavo, Imre; Yu, Maria; Robertson, Kenneth E.; Zhang, Nan; Giorgino, Francesco (2018)
Efficacy and safety of MK-1293 insulin glargine compared with originator insulin glargine (Lantus) in type 1 diabetes: A randomized, open-label clinical trial

Home, Philip D.; Lam, Raymond L. H.; Carofano, Wendy L.; Golm, Gregory T.; Eldor, Roy; Crutchlow, Michael F.; Marcos, Michael C.; Rosenstock, Julio; Hollander, Priscilla A.; Gallwitz, Baptist (2018)
Efficacy and safety of MK-1293 insulin glargine compared with originator insulin glargine (Lantus) in type 2 diabetes: A randomized, open-label clinical trial

Hollander, Priscilla A.; Carofano, Wendy L.; Lam, Raymond L. H.; Golm, Gregory T.; Eldor, Roy; Crutchlow, Michael F.; Marcos, Michael C.; Rendell, Marc S.; Home, Philip D.; Gallwitz, Baptist; Rosenstock, Julio (2018)
Empagliflozin – Insulinunabhängige Kontrolle der Glykämieparameter bei Diabetes mellitus Typ 2 durch Inhibition des Natrium-Glukose-Cotransporters SGLT2

Gallwitz, B.; Merker, L.; Hohberg, C.; Schmid, V.; Moennig, E.; Brendel, M. D. (2015)
Exenatide twice daily versus glimepiride for prevention of glycaemic deterioration in patients with type 2 diabetes with metformin failure (EUREXA): an open-label, randomised controlled trial

Gallwitz, Baptist; Guzman, Juan; Dotta, Francesco; Guerci, Bruno; Simo, Rafael; Basson, Bruce R.; Festa, Andreas; Kiljanski, Jacek; Sapin, Helene; Trautmann, Michael; Schernthaner, Guntram (2012)
Extra-pancreatic effects of incretin-based therapies

Gallwitz, Baptist (2014)

Anzeige der Dokumente 1-20 von 72

Nächste Seite >>

Publikation melden

Hilfe und Informationen

Stöbern

Gesamter Bestand
In diesem Bereich

Mein Benutzerkonto

Einloggen

Auflistung Universitätsbibliographie nach Autor "Gallwitz, Baptist"

DSpace Repositorium (Manakin basiert)

Auflistung Universitätsbibliographie nach Autor "Gallwitz, Baptist"

Stöbern

Gesamter Bestand

In diesem Bereich

Mein Benutzerkonto